ישראל - עברית - Ministry of Health

pharmalogic ltd - methotrexate 10 mg/ml - solution for injection - methotrexate - antineoplastic chemotherapy: treatment of gestational choriocarcinoma, chorioadenoma destruents and hydatidiform mole. palliation of acute lymphocytic leukemia. in the treatment and prophylaxis of meningeal leukemia. greatest effect has been observed in palliation of acute lymphoblastic (stem cell) leukemias in children. in combination with other anticancer agents, methotrexate may be used for the induction of remission, but is most commonly used in maintenance of induced remissions. abitrexate may be used alone or in combination with other antineoplastics in the management of breast cancer, epidermoid cancers of the head and neck, lung cancer (particularly squamous cell and small cell types), bladder cancer and osteogenic cancer. methotrexate is effective in the treatment of the advanced stages (iii and iv peter's staging system) of lymphosarcoma, particularly in children, and in advanced cases of mycosis fungoides. psoriasis: because of the high risk attending its use, methotrexate is indicated only in the

ישראל - עברית - Ministry of Health

linevitz eliezer - ivermectin 18.7 mg/g - paste - control the following horse parasites: large redworms: adult and arterial and 4-th larval ( arterial) stage of strongylus vulgaris adults and 4-th larval (tissue) stages of s. edentatus (adults) of s.eguinus. small redworm: adult and developing immatures (4-th stage larval) of the following species of small stronyles or cyathostomes: triodontophorus spp. (adults) coroncyclus spp. cyathostomum spp. cylococyclus spp. cylicostephanus spp. poteriostomum spp. (ivermectin is not effictive against encysted larval stages of the small strongyles.) pinworms: adult adn immature oxyuris equi. lungworms: adult and immature dictyocaulus arnfieldi. ascarids: adult and immature parascaris equorum. stomach worms: trichostrongylus axei and habronema muscae. intestinal threadworms: strongyloides westeri. cutaneous worms: microfilariae of onchocerca spp. bots: mouth and stomach stages of gasterophilus spp.

ישראל - עברית - Ministry of Health

intervet ( israel) ltd - flunixin as meglumine - תמיסה להזרקה - flunixin as meglumine 50 mg/ml

ישראל - עברית - Ministry of Health

comex ltd - flunixin as meglumine - תמיסה להזרקה - flunixin as meglumine 50 mg/ml

ישראל - עברית - Ministry of Health

rekah pharmaceutical industry ltd, israel - papaverine hydrochloride - טבליה - papaverine hydrochloride 40 mg - papaverine - papaverine - treatment of arterial spasm.

ישראל - עברית - Ministry of Health

medic trim healthcare ltd - heparin sodium 5000 iu/ml - solution for injection - heparin - anticoagulant, treatment of arterial and venous thrombosis, prevention of thromo-embolic complications after surgery.

ישראל - עברית - Ministry of Health

pharmalogic ltd - heparin sodium - תמיסה להזרקה\אינפוזיה - heparin sodium 5000 iu/ml - heparin - heparin - treatment of thrombo-embolic disorders as deep vein thrombosis, acute arterial embolism or thrombosis, thrombophlebitis, pulmonary embolism , fat embolism. prophylaxis of deep vein thrombosis and thromboembolic events.

ישראל - עברית - Ministry of Health

sanofi - aventis israel ltd - enoxaparin sodium - תמיסה להזרקה - enoxaparin sodium 150 mg/ml - enoxaparin - enoxaparin - for treatment of deep vein thrombosis (dvt) once daily. treatment of pulmonary embolism once daily.

ישראל - עברית - Ministry of Health

sanofi israel ltd - clopidogrel as hydrogen sulfate - טבליות מצופות פילם - clopidogrel as hydrogen sulfate 75 mg - clopidogrel - clopidogrel - prevention of atherotrobmotic eventsclopidogrel is indicated in :• adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.• adult patients suffering from acute coronary syndrome- non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave myocardial infarction (mi)), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapyprevention of atherotrobmotic and thromboembolic events in atrial fibrillation: in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for the treatment with vitamin k antagonists (vka) anti-thrombin or anti factor xa, and who have a low bleeding risk, clopid

ישראל - עברית - Ministry of Health

sanofi - aventis israel ltd - clopidogrel as hydrogen sulfate 300 mg - film coated tablets - clopidogrel - prevention of atherotrobmotic eventsclopidogrel is indicated in :• adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.• adult patients suffering from acute coronary syndrome- non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave myocardial infarction (mi)), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapyprevention of atherotrobmotic and thromboembolic events in atrial fibrillation: in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for the treatment with vitamin k antagonists (vka) anti-thrombin or anti factor xa, and who have a low bleeding risk, clopid